TyraTech, Inc. Lloyds and Day Lewis Pharmacy listings (7733F)
February 25 2015 - 02:00AM
UK Regulatory
TIDMTYR TIDMTYRU
RNS Number : 7733F
TyraTech, Inc.
25 February 2015
25 February 2015
TyraTech, Inc.
("TyraTech" or the "Company")
Lloyds and Day Lewis Pharmacy listings
Vamousse(R) Advertising and Marketing Award
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company
focused on nature-derived insect and parasite control products, is
delighted to announce new listings for its Vamousse(R) Head Lice
Treatment and Protective products with Lloyds Pharmacy and its
Treatment product with Day Lewis Pharmacy in the UK.
Day Lewis, which began stocking the Vamousse range in January
2015, is the largest independent pharmacy chain in the UK with more
than 200 outlets. Lloyds, a well respected household name at the
forefront of community pharmacy, has a distribution network of more
than 1600 outlets in the UK and is expected to commence stocking
Vamousse products from March 2015.
Vamousse - broadening the distribution network
With distribution already established in Boots, Superdrug,
Sainsbury's, Tesco and Rowlands, the addition of Lloyds and Day
Lewis gives Vamousse a comprehensive UK distribution platform for
2015. Increasing the physical distribution points is particularly
important for head lice products that tend to be emergency
purchases. Customers need to be able to find the products close to
home in order to solve their head lice problems as fast as
possible.
Vamousse - advertising and marketing campaign award
TyraTech is particularly pleased that the Vamousse brand has won
the Independent Community Pharmacy (ICP) magazine 'Pharmacy Product
Of The Year - Best Advertising Campaign' award. This prestigious
award is voted for by practicing pharmacists. The award recognises
and reflects the strong awareness and engagement generated by the
Vamousse marketing campaign amongst pharmacists and pharmacy staff.
Their awareness and recommendation of the Vamousse Treatment and
Protective range are key ingredients in the commercial success of
these products.
Bruno Jactel CEO of TyraTech commented:
"We are delighted to announce these new listings for our
Vamousse treatment and preventative products, taking us initially
into more than 1300 new distribution points in the UK from March
2015.
"I am very pleased with our achievements in the UK marketplace
in the eight months since the launch of the Vamousse product range.
We are confident of continued positive developments as our
comprehensive UK distribution platform reaps the benefits of our
highly engaging and effective marketing campaign."
For further information please contact:TyraTech, Inc.
Bruno Jactel, Chief Executive Officer Tel: +1 919 415 4340
Vincent Morgus, Chief Financial Officer and Tel: +1 919 415 4287
Treasurer
SPARK Advisory Partners Limited, Nominated
Adviser Tel: +44 20 3368 3550
Matt Davis / Mark Brady
Allenby Capital Limited, Joint Broker
Chris Crawford Tel: +44 20 3328 5656
Whitman Howard Limited, Joint Broker
Ranald McGregor-Smith / Niall Devins Tel: +44 20 7087
4555
Walbrook, Financial PR and IR
Nick Rome/ Guy McDougall Tel: +44 20 7933 8780
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPKQDQOBKDNBB
Tyratech (LSE:TYR)
Historical Stock Chart
From Feb 2024 to Mar 2024
Tyratech (LSE:TYR)
Historical Stock Chart
From Mar 2023 to Mar 2024